HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
doi:10.21037/tau.2018.04.11 Shiraishi K, Ohmi C, Matsuyama H
The PTSD Checklist (PCL): Reliability, Validity, and Diagnostic Utility
But science means nothing if you cannot translate it into action
The Vitamin C that is present brings about more collagen production and increases the skins antioxidant defense capacity
Peptide Sci